138 related articles for article (PubMed ID: 12477508)
1. A randomized, placebo-controlled trial of the effects of continuous combined hormone replacement therapy on coagulation and fibrinolytic systems in healthy postmenopausal women.
Salobir BG; Keber I; Vrabic L
Fertil Steril; 2002 Dec; 78(6):1178-83. PubMed ID: 12477508
[TBL] [Abstract][Full Text] [Related]
2. Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis.
Teede HJ; McGrath BP; Smolich JJ; Malan E; Kotsopoulos D; Liang YL; Peverill RE
Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1404-9. PubMed ID: 10807761
[TBL] [Abstract][Full Text] [Related]
3. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
[TBL] [Abstract][Full Text] [Related]
4. Effects of tibolone and continuous combined hormone replacement therapy on parameters in the clotting cascade: a multicenter, double-blind, randomized study.
Winkler UH; Altkemper R; Kwee B; Helmond FA; Coelingh Bennink HJ
Fertil Steril; 2000 Jul; 74(1):10-9. PubMed ID: 10899490
[TBL] [Abstract][Full Text] [Related]
5. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial.
Scarabin PY; Alhenc-Gelas M; Plu-Bureau G; Taisne P; Agher R; Aiach M
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3071-8. PubMed ID: 9409295
[TBL] [Abstract][Full Text] [Related]
6. Low-dose oral combination of 17beta-estradiol and norethisterone acetate in postmenopausal women decreases factor VII, fibrinogen, antithrombin and plasminogen activator inhibitor-1.
Borgfeldt C; Li C; Samsioe G
Climacteric; 2004 Mar; 7(1):78-85. PubMed ID: 15259286
[TBL] [Abstract][Full Text] [Related]
7. Hemostatic markers in healthy postmenopausal women during intranasal and oral hormone therapy: a randomized trial.
Hemelaar M; Kenemans P; Hack CE; Klipping C; van der Mooren MJ
Menopause; 2008; 15(2):248-55. PubMed ID: 17693902
[TBL] [Abstract][Full Text] [Related]
8. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
Fertil Steril; 2001 Mar; 75(3):554-9. PubMed ID: 11239541
[TBL] [Abstract][Full Text] [Related]
9. Positive impact of hormone replacement therapy on the fibrinolytic system: a long-term randomized controlled study in healthy postmenopausal women.
Madsen JS; Kristensen SR; Gram J; Bladbjerg EM; Henriksen FL; Gram J; Christensen K; Jespersen J
J Thromb Haemost; 2003 Sep; 1(9):1984-91. PubMed ID: 12941041
[TBL] [Abstract][Full Text] [Related]
10. Effects of raloxifene and continuous combined hormone therapy on haemostasis variables: a multicenter, randomized, double-blind study.
Sgarabotto M; Baldini M; Dei Cas A; Manotti C; Luciana Barilli A; Rinaldi M; Benassi L; Bacchi Modena A
Thromb Res; 2007; 119(1):85-91. PubMed ID: 16499954
[TBL] [Abstract][Full Text] [Related]
11. Double blind, randomized study of estradiol replacement therapy on markers of inflammation, coagulation and fibrinolysis.
Zegura B; Keber I; Sebestjen M; Koenig W
Atherosclerosis; 2003 May; 168(1):123-9. PubMed ID: 12732395
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers.
Stevenson JC; Oladipo A; Manassiev N; Whitehead MI; Guilford S; Proudler AJ
Br J Haematol; 2004 Mar; 124(6):802-8. PubMed ID: 15009069
[TBL] [Abstract][Full Text] [Related]
13. Effects of hormone replacement therapy on coagulation and fibrinolysis in postmenopausal women.
Koh KK
Int J Hematol; 2002 Aug; 76 Suppl 2():44-6. PubMed ID: 12430899
[TBL] [Abstract][Full Text] [Related]
14. The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial.
Høibraaten E; Qvigstad E; Andersen TO; Mowinckel MC; Sandset PM
Thromb Haemost; 2001 May; 85(5):775-81. PubMed ID: 11372667
[TBL] [Abstract][Full Text] [Related]
15. Anti-ischemic action of estrogen-progestogen continuous combined hormone replacement therapy in postmenopausal women with established angina pectoris: a randomized, placebo-controlled, double-blind, parallel-group trial.
Sanderson JE; Haines CJ; Yeung L; Yip GW; Tang K; Yim SF; Jorgensen LN; Woo J
J Cardiovasc Pharmacol; 2001 Sep; 38(3):372-83. PubMed ID: 11486242
[TBL] [Abstract][Full Text] [Related]
16. Effects of low-dose oral and transdermal estrogen replacement therapy on hemostatic factors in healthy postmenopausal women: a randomized placebo-controlled study.
Post MS; van der Mooren MJ; van Baal WM; Blankenstein MA; Merkus HM; Kroeks MV; Franke HR; Kenemans P; Stehouwer CD
Am J Obstet Gynecol; 2003 Nov; 189(5):1221-7. PubMed ID: 14634544
[TBL] [Abstract][Full Text] [Related]
17. Haemostatic risk factors in healthy postmenopausal women taking hormone replacement therapy.
Norris LA; Joyce M; O'Keeffe N; Sheppard BL; Bonnar J
Maturitas; 2002 Oct; 43(2):125-33. PubMed ID: 12385861
[TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy does not affect the 24-hour heart rate variability in postmenopausal women: results of a randomized, placebo-controlled trial with two regimens.
Fernandes EO; Moraes RS; Ferlin EL; Wender MC; Ribeiro JP
Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S172-7. PubMed ID: 15683490
[TBL] [Abstract][Full Text] [Related]
19. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy in healthy postmenopausal women: a randomized, placebo-controlled study of effects on coagulation and fibrinolytic factors.
Gottsäter A; Rendell M; Hulthén UL; Berntorp E; Mattiasson I
J Intern Med; 2001 Mar; 249(3):237-46. PubMed ID: 11285043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
